Polypill for prevention of cardiovascular diseases
نویسندگان
چکیده
منابع مشابه
Statins alone or polypill for primary prevention of cardiovascular diseases
Cardiovascular disease (CVD), the leading cause of death and disability worldwide, imposes huge healthcare costs to society and significant burdens to patients. It is estimated that 18 million deaths occurred from CVD annually worldwide [1]. Over three quarters of CVD deaths take place in lowand middle-income countries including Iran. Therefore, developing and implementing public health strateg...
متن کاملStrengths and Limitations of Using the Polypill in Cardiovascular Prevention
PURPOSE OF REVIEW Polypill and its role in cardiovascular disease (CVD) prevention has been extensively discussed and debated since the inception of the concept in 2003. This article reviews the subsequent accumulated research in this area. RECENT FINDINGS Several short and intermediate to long-term studies with different brands of polypills have analysed the impact of polypill in phase II an...
متن کاملThe polypill in the primary prevention of cardiovascular disease.
Coronary heart disease (CHD) and stroke are the most common causes of death worldwide. The polypill, a multi-component tablet or capsule designed to reduce several cardiovascular causal risk factors simultaneously, has the potential to reduce the incidence of heart attacks and stroke by about 80%, the precise reduction depending on the formulation of the polypill and adherence to preventive tre...
متن کاملPrevention of cardiovascular diseases
Cardiovascular disease (CVD) is the most important cause of premature death and disability globally. Much is known of the main aetiological risk factors, including elevated blood pressure, dyslipidaemia and smoking, with a raft of additional risks of increasing prevalence, such as obesity and diabetes. Furthermore, some of the most secure evidence-based management strategies in healthcare relat...
متن کاملPrevention of Cardiovascular Diseases
O ver the past two decades, the United States has witnessed noteworthy increases in life expectancy and major decreases in the death toll attributed to cardiovascular diseases (CVD). Ageadjusted death rates from coronary heart disease (CHD) are now half what they were 20 years ago, and death rates from stroke have declined even more sharply. It is well recognized that research in epidemiology a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 2020
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(19)33002-8